AR107967A1 - Ácido hialurónico modificado, método para su preparación y usos del mismo - Google Patents

Ácido hialurónico modificado, método para su preparación y usos del mismo

Info

Publication number
AR107967A1
AR107967A1 ARP170100730A ARP170100730A AR107967A1 AR 107967 A1 AR107967 A1 AR 107967A1 AR P170100730 A ARP170100730 A AR P170100730A AR P170100730 A ARP170100730 A AR P170100730A AR 107967 A1 AR107967 A1 AR 107967A1
Authority
AR
Argentina
Prior art keywords
preparation
hyaluronic acid
same
hydrogel
modified hyaluronic
Prior art date
Application number
ARP170100730A
Other languages
English (en)
Original Assignee
Merz Pharma Gmbh & Co Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co Kgaa filed Critical Merz Pharma Gmbh & Co Kgaa
Publication of AR107967A1 publication Critical patent/AR107967A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/20Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52Hydrogels or hydrocolloids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00Processes of treating or compounding macromolecular substances
    • C08J3/02Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media
    • C08J3/075Macromolecular gels
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91Injection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402Anaestetics, analgesics, e.g. lidocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/34Materials or treatment for tissue regeneration for soft tissue reconstruction
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/08Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00Applications
    • C08L2203/02Applications for biomedical use

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente se relaciona, en general, con un ácido hialurónico modificado (HA) y con un método para su preparación, más específicamente con un derivado HA modificado con (poli)glicerol preparado mediante el injerto de glicidol en HA. La presente también se relaciona con el uso del derivado de HA para la preparación de una composición de relleno dérmico, un hidrogel que comprende HA entrecruzado y el derivado de HA modificado con (poli)glicerol, y un método para la preparación de dicho hidrogel. Además, la presente se relaciona con el uso del hidrogel como producto cosmético y/o estético, en particular como relleno dérmico para relleno, reemplazo y/o aumento de tejidos.
ARP170100730A 2016-03-24 2017-03-23 Ácido hialurónico modificado, método para su preparación y usos del mismo AR107967A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16000715 2016-03-24

Publications (1)

Publication Number Publication Date
AR107967A1 true AR107967A1 (es) 2018-07-04

Family

ID=55642206

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170100730A AR107967A1 (es) 2016-03-24 2017-03-23 Ácido hialurónico modificado, método para su preparación y usos del mismo

Country Status (16)

Country Link
US (1) US10640578B2 (es)
EP (1) EP3433284A1 (es)
JP (1) JP6946323B2 (es)
KR (1) KR102316644B1 (es)
CN (1) CN108779185B (es)
AR (1) AR107967A1 (es)
AU (1) AU2017237457B2 (es)
BR (1) BR112018068559B8 (es)
CA (1) CA3016272A1 (es)
IL (1) IL261574B2 (es)
MX (1) MX2018011053A (es)
RU (1) RU2733444C2 (es)
SG (1) SG11201807185UA (es)
TW (1) TWI727014B (es)
WO (1) WO2017162676A1 (es)
ZA (1) ZA201805424B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7501908B2 (ja) * 2017-09-19 2024-06-18 香港科技大学 生体適合性材料、並びにそれを作製及び使用する方法
US20210008249A1 (en) 2018-03-12 2021-01-14 Merz Pharma Gmbh & Co. Kgaa Porous biomaterials for tissue regeneration
AU2019407867B2 (en) * 2018-12-19 2024-09-26 Merz Pharma Gmbh & Co. Kgaa Aldehyde-modified hyaluronic acid, method for preparing same and applications thereof
BR112021012042A2 (pt) * 2018-12-20 2021-09-21 Lg Chem, Ltd. Preenchedor com excelentes propriedades de preenchedor compreendendo hidrogel de ácido hialurônico
EP4038105B1 (en) * 2019-10-01 2024-01-10 Biopolimeri S.r.l. A hyperbranched polyglycerol polyglycidyl ether and its use as crosslinker for polysaccharides
FR3111903B1 (fr) 2020-06-24 2022-12-02 Lab Vivacy Procede d’incorporation de composes organiques en solution au sein d’un hydrogel
FR3113522A1 (fr) 2020-08-20 2022-02-25 Laboratoires Vivacy procédé d’évaluation des caractéristiques rhéologiques d’un gel
TW202317214A (zh) 2021-06-23 2023-05-01 德商莫茲製藥有限兩合公司 以絲蛋白交聯多醣及所得材料之用途
CN118742576A (zh) 2022-01-11 2024-10-01 维库有限公司 作为创新填充剂的新透明质酸衍生物
ES2947097A1 (es) * 2022-02-01 2023-08-01 Martinez Miguel Angel Gomariz Metodo cosmetico de rejuvenecimiento de la piel
FR3135399A1 (fr) 2022-03-30 2023-11-17 Laboratoires Vivacy émulsion comprenant un hydrogel et de la graisse ou un dérivé de graisse
WO2024126649A1 (en) 2022-12-15 2024-06-20 Merz Pharma Gmbh & Co. Kgaa Injectable gel comprising botulinum toxin and uses thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61150844A (ja) 1984-12-21 1986-07-09 Meidensha Electric Mfg Co Ltd 電鉄用回生インパ−タの制御方法
TWI251596B (en) * 2002-12-31 2006-03-21 Ind Tech Res Inst Method for producing a double-crosslinked hyaluronate material
FR2865737B1 (fr) 2004-02-03 2006-03-31 Anteis Sa Gel reticule biocompatible
WO2006025556A1 (en) * 2004-08-31 2006-03-09 Showa Denko K.K. Surface-modified packing material for liquid chromatography and production method thereof
JP5022618B2 (ja) * 2005-04-05 2012-09-12 株式会社 資生堂 ヒドロキシアルキル化ヒアルロン酸
KR100849185B1 (ko) * 2006-01-19 2008-07-30 서울산업대학교 산학협력단 키토산 또는 히알루론산-폴리에틸렌옥사이드 및키토산-히알루론산-폴리에틸렌옥사이드를 기저로 하는하이드로젤과  이의 제조방법
WO2008034176A1 (en) * 2006-09-19 2008-03-27 Ultraceuticals R & D Pty Ltd Cross-linked polysaccharide gels
FR2909560B1 (fr) 2006-12-06 2012-12-28 Fabre Pierre Dermo Cosmetique Gel d'acide hyaluronique pour injection intradermique
CN101502677B (zh) * 2008-02-04 2013-06-26 凌沛学 一种注射用交联透明质酸钠凝胶及其制备方法
CN101538377A (zh) * 2008-03-20 2009-09-23 上海昊海生物科技有限公司 一种交联透明质酸凝胶及其制备方法
US8357795B2 (en) * 2008-08-04 2013-01-22 Allergan, Inc. Hyaluronic acid-based gels including lidocaine
US9371402B2 (en) * 2009-04-09 2016-06-21 Scivision Biotech Inc. Method for producing cross-linked hyaluronic acid
US20100261893A1 (en) * 2009-04-09 2010-10-14 Scivision Biotech Inc. Method for producing cross-linked hyaluronic acid
FR2945949B1 (fr) * 2009-05-26 2011-05-13 Anteis Sa Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme.
EP2459239A1 (en) * 2009-07-30 2012-06-06 Carbylan Biosurgery, Inc. Modified hyaluronic acid polymer compositions and related methods
KR101726016B1 (ko) * 2010-02-19 2017-04-11 큐피가부시키가이샤 치환 히알루론산 및/또는 그 염, 그리고 그 제조 방법 및 이것을 함유하는 화장료
BR112013003895A2 (pt) * 2010-08-19 2016-07-12 Merz Pharma Gmbh & Co Kgaa composição de enchimento e seu uso, processo para a preparação da composição de enchimento, kit e dispositivo de injeção
RU2496793C1 (ru) * 2012-06-14 2013-10-27 Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук Способ получения 2,3-дигидроксипропилхитозана
BR112014031412B1 (pt) 2012-06-15 2021-01-05 Merz Pharma Gmbh & Co. Kgaa método de preparação de uma composição
US20140275340A1 (en) 2013-03-15 2014-09-18 Lake Region Manufacturing, Inc. d/b/a Lake Region Medical Modified hyaluronate hydrophilic compositions, coatings and methods
FR3006689A1 (fr) * 2013-06-11 2014-12-12 Benedicte Vincente Tauzin Procede de reticulation de l'acide hyaluronique; procede de preparation d'un hydrogel injectable; hydrogel obtenu; utilisation de l'hydroget obtenu
AR099900A1 (es) * 2014-04-01 2016-08-24 Merz Pharma Gmbh & Co Kgaa Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso
CN104194008B (zh) * 2014-08-08 2017-09-15 陕西佰傲再生医学有限公司 一种交联透明质酸凝胶微粒及其制备方法

Also Published As

Publication number Publication date
CA3016272A1 (en) 2017-09-28
EP3433284A1 (en) 2019-01-30
IL261574B2 (en) 2024-03-01
JP6946323B2 (ja) 2021-10-06
KR102316644B1 (ko) 2021-10-26
SG11201807185UA (en) 2018-09-27
WO2017162676A1 (en) 2017-09-28
MX2018011053A (es) 2019-03-28
KR20180127983A (ko) 2018-11-30
CN108779185A (zh) 2018-11-09
RU2018129659A3 (es) 2020-05-27
IL261574B1 (en) 2023-11-01
AU2017237457A1 (en) 2018-09-06
BR112018068559B8 (pt) 2022-11-01
US10640578B2 (en) 2020-05-05
RU2733444C2 (ru) 2020-10-01
JP2019509385A (ja) 2019-04-04
CN108779185B (zh) 2021-09-17
TWI727014B (zh) 2021-05-11
TW201805008A (zh) 2018-02-16
BR112018068559A2 (pt) 2019-04-16
IL261574A (en) 2018-10-31
ZA201805424B (en) 2019-04-24
BR112018068559B1 (pt) 2022-09-20
US20190100605A1 (en) 2019-04-04
AU2017237457B2 (en) 2021-04-08
RU2018129659A (ru) 2020-04-24

Similar Documents

Publication Publication Date Title
AR107967A1 (es) Ácido hialurónico modificado, método para su preparación y usos del mismo
BR112017008726A2 (pt) usos de um extrato de fermento e de um exopolissacarídeo, e, composição cosmética.
EP4062900A3 (en) Skin care cosmetic composition
GT201400043A (es) Imidazopiridazinas sustituidas con amino
BR112017008344A2 (pt) extrato, uso de um extrato, e, composição cosmética ou dermofarmacêutica.
UY35040A (es) Pirrolopirimidinilamino-benzotiazolonas sustituidas
CL2020002915A1 (es) Composiciones para el tratamiento de condiciones de la piel
PE20151759A1 (es) Imidazopiridazinas sustituidas
DOP2017000146A (es) Pirazolpiridinaminas como inhibidores de mknk1 y mknk2
BR112017024013A2 (pt) composições compreendendo células tronco mesenquimatosas e seus usos
EA201991679A1 (ru) Способ получения и композиции кожного наполнителя, содержащие гиалуроновую кислоту и гидроксиапатит
CL2018001104A1 (es) Composición para el cuidado de la piel y procedimiento asociado.
MX2017002469A (es) Composiciones de matrices extracelulares.
BR112016022394A2 (pt) Composição farmaceuticamente aceitável, composição na forma de uma solução injetável farmaceuticamente aceitável, uso da composição, e, método para a preparação da composição injetável farmaceuticamente aceitável
UY35651A (es) Pirazolpiridinas sustituidas
AR100618A1 (es) Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
CL2020000267A1 (es) Complejo cosmético para la hidratación bioactiva, composición cosmética, uso y método.
CO2017003798A2 (es) Método de tratamiento para antibrote de tubérculos con cantidad reducida de cipc
CL2020002646A1 (es) Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado de casearia sylvestris y schinus terebinthfolius y ácido hialurónico (divisional de la solicitud 03354-2018)
EA201500830A1 (ru) Противогрибковая композиция для наружного применения для лечения онихомикоза
AR114314A1 (es) Carbonato de calcio tratado mediante reacción superficial para modificar las propiedades biomecánicas de la piel
BR112019005391A2 (pt) métodos para preparar uma composição de hidrogel injetável esterilizada e para tratar cosmeticamente a pele, e, composição de hidrogel injetável esterilizada.
AR107195A1 (es) Composición lípida vegetal para promover el crecimiento del cabello, método para promover el crecimiento del cabello y uso de dichos lípidos vegetales
MX2020004257A (es) Uso cosmetico de un extracto de marfil vegetal (phytelephas sp.).
CL2021001183A1 (es) Composición cosmética, método para la producción de aceite y/o manteca de astrocaryum vulgare, uso de la composición cosmética y método para la producción y/o protección contra la degradación del ácido hialurónico en la piel

Legal Events

Date Code Title Description
FG Grant, registration